Variant report

Variant	rs2034891
Chromosome Location	chr19:52004747-52004748
allele	G/T
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	MAFK	chr19:52004747-52004973	K562	blood:	n/a	n/a

Variant related genes	Relation type
SIGLEC12	TF binding region

Extended variants
information (count: 34 )
Associated
traits (count: 0)

rSNPs within LD-proxies of this variant (count:26)

rs_ID	r²[population]
rs10402495	0.92[ASN][1000 genomes]
rs10419489	0.92[ASN][1000 genomes]
rs10421023	1.00[CHB][hapmap];0.95[CHD][hapmap];0.90[JPT][hapmap];0.92[ASN][1000 genomes]
rs10421468	1.00[CHB][hapmap];0.90[JPT][hapmap];0.92[ASN][1000 genomes]
rs12461323	0.95[ASN][1000 genomes]
rs12461345	0.90[EUR][1000 genomes];0.95[ASN][1000 genomes]
rs12463300	0.88[CHD][hapmap];0.81[JPT][hapmap]
rs1551555	0.81[YRI][hapmap]
rs2034889	0.93[ASN][1000 genomes]
rs2034890	0.95[EUR][1000 genomes]
rs3810105	1.00[CHB][hapmap];1.00[CHD][hapmap];0.95[GIH][hapmap];0.90[JPT][hapmap];1.00[TSI][hapmap];0.87[AMR][1000 genomes];0.95[EUR][1000 genomes];0.95[ASN][1000 genomes]
rs62116175	0.86[AMR][1000 genomes];0.90[EUR][1000 genomes];0.95[ASN][1000 genomes]
rs62116177	0.86[AMR][1000 genomes];0.95[EUR][1000 genomes];0.95[ASN][1000 genomes]
rs62116178	0.92[ASN][1000 genomes]
rs62116179	0.92[ASN][1000 genomes]
rs7246846	0.86[CHB][hapmap];0.89[CHD][hapmap];0.90[JPT][hapmap];0.90[ASN][1000 genomes]
rs8106598	0.89[CHD][hapmap]
rs8110247	1.00[CHB][hapmap];0.95[CHD][hapmap];0.90[JPT][hapmap];0.92[ASN][1000 genomes]
rs8113414	1.00[CHB][hapmap];0.89[JPT][hapmap];0.88[YRI][hapmap];0.87[AFR][1000 genomes];0.86[AMR][1000 genomes];0.95[EUR][1000 genomes];0.95[ASN][1000 genomes]
rs9304717	0.92[ASN][1000 genomes]
rs962129	0.86[CHB][hapmap];0.88[CHD][hapmap];0.90[JPT][hapmap];0.88[ASN][1000 genomes]
rs962130	0.86[CHB][hapmap];0.89[CHD][hapmap];0.90[JPT][hapmap];0.88[ASN][1000 genomes]
rs9676254	1.00[CHB][hapmap];0.95[CHD][hapmap];0.90[JPT][hapmap];0.92[ASN][1000 genomes]
rs9676256	1.00[CHB][hapmap];0.95[CHD][hapmap];0.90[JPT][hapmap];0.92[ASN][1000 genomes]
rs9676266	1.00[CHB][hapmap];0.95[CHD][hapmap];0.90[JPT][hapmap];0.92[ASN][1000 genomes]
rs9676272	1.00[CHB][hapmap];0.90[CHD][hapmap];0.90[JPT][hapmap]

Variant overlapped rSNPs/rCNVs (count:8 , 50 per page) page: 1

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	nsv1066308	chr19:51680133-52103974	Active TSS Weak transcription Flanking Active TSS Enhancers Strong transcription ZNF genes & repeats Genic enhancers Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	71 gene(s)	inside rSNPs	diseases
2	nsv544049	chr19:51680133-52103974	Bivalent Enhancer Strong transcription Enhancers Active TSS Flanking Bivalent TSS/Enh Weak transcription Flanking Active TSS ZNF genes & repeats Genic enhancers Bivalent/Poised TSS Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	71 gene(s)	inside rSNPs	diseases
3	nsv544051	chr19:51944903-52147459	Bivalent Enhancer Strong transcription Weak transcription Active TSS ZNF genes & repeats Flanking Active TSS Enhancers Genic enhancers Bivalent/Poised TSS Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	26 gene(s)	inside rSNPs	diseases
4	esv2758504	chr19:51991896-52266700	Enhancers Strong transcription Transcr. at gene 5' and 3' Weak transcription Active TSS ZNF genes & repeats Flanking Active TSS Genic enhancers Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	542 gene(s)	inside rSNPs	diseases
5	esv2758767	chr19:51991896-52604625	Flanking Active TSS Transcr. at gene 5' and 3' ZNF genes & repeats Weak transcription Active TSS Bivalent/Poised TSS Genic enhancers Flanking Bivalent TSS/Enh Strong transcription Enhancers Bivalent Enhancer	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	578 gene(s)	inside rSNPs	diseases
6	nsv469584	chr19:52001381-52151821	Enhancers Weak transcription Flanking Active TSS ZNF genes & repeats Active TSS Genic enhancers Transcr. at gene 5' and 3' Strong transcription Flanking Bivalent TSS/Enh Bivalent Enhancer Bivalent/Poised TSS	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	25 gene(s)	inside rSNPs	diseases
7	nsv482654	chr19:52001381-52151821	Enhancers Strong transcription Weak transcription Bivalent Enhancer Active TSS Flanking Active TSS Genic enhancers ZNF genes & repeats Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Bivalent/Poised TSS	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	25 gene(s)	inside rSNPs	diseases
8	esv33175	chr19:52002098-52010839	Enhancers Flanking Active TSS Weak transcription ZNF genes & repeats Bivalent Enhancer Active TSS Flanking Bivalent TSS/Enh	TF binding region CpG island Chromatin interactive region	6 gene(s)	inside rSNPs	diseases

No data

Chromatin state (count:27 , 50 per page) page: 1

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr19:52002600-52015000	Enhancers	Primary monocytes fromperipheralblood	blood
2	chr19:52003600-52004800	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Male	--
3	chr19:52003800-52004800	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
4	chr19:52004200-52005000	Enhancers	Primary T helper naive cells fromperipheralblood	blood
5	chr19:52004200-52007000	Flanking Active TSS	Monocytes-CD14+_RO01746	blood
6	chr19:52004200-52007400	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Female	--
7	chr19:52004400-52005600	Enhancers	Primary B cells from peripheral blood	blood
8	chr19:52004400-52005600	Enhancers	Primary hematopoietic stem cells	blood
9	chr19:52004400-52006000	Enhancers	K562	blood
10	chr19:52004600-52004800	Enhancers	Primary T cells from cord blood	blood
11	chr19:52004600-52004800	Bivalent Enhancer	Adipose Nuclei	Adipose
12	chr19:52004600-52005000	Enhancers	Primary T helper naive cells from peripheral blood	blood
13	chr19:52004600-52005000	Enhancers	Colonic Mucosa	Colon
14	chr19:52004600-52005000	Active TSS	Duodenum Mucosa	Duodenum
15	chr19:52004600-52005000	Enhancers	Fetal Thymus	thymus
16	chr19:52004600-52005000	Active TSS	Rectal Mucosa Donor 29	rectum
17	chr19:52004600-52005200	Flanking Active TSS	Primary neutrophils fromperipheralblood	blood
18	chr19:52004600-52005200	Bivalent Enhancer	Primary T cells fromperipheralblood	blood
19	chr19:52004600-52005200	Flanking Active TSS	Primary hematopoietic stem cells short term culture	blood
20	chr19:52004600-52005200	Enhancers	Primary T helper cells fromperipheralblood	blood
21	chr19:52004600-52005200	Enhancers	Primary T regulatory cells fromperipheralblood	blood
22	chr19:52004600-52005400	Enhancers	Primary T helper cells PMA-I stimulated	--
23	chr19:52004600-52005800	Enhancers	Primary B cells from cord blood	blood
24	chr19:52004600-52005800	Enhancers	Primary mononuclear cells fromperipheralblood	Blood
25	chr19:52004600-52005800	Enhancers	Placenta	Placenta
26	chr19:52004600-52006000	Enhancers	Primary Natural Killer cells fromperipheralblood	blood
27	chr19:52004600-52006000	Enhancers	Spleen	Spleen

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links